- Sexual dimorphism in right ventricular adaptation to pressure overload involves differential angiogenic response
American Journal of Physiology-Heart and Circulatory Physiology · 2025
- Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair
European Heart Journal · 2025
- Impact of sodium–glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis
European Journal of Preventive Cardiology · 2025
- Clinical Features and Inhospital Outcomes of Takotsubo (Stress) Cardiomyopathy: Ten Years’ Experience from a Tertiary Care Center in South India
Journal of Indian College of Cardiology · 2025
- Cardiac dilation, energy stress, and ventricular remodeling: insights from prolonged voluntary exercise in male mice with TAC-induced HFpEF
Journal of Applied Physiology · 2025
- Digital Home-Based Self-Monitoring System for People with Heart Failure: Protocol for Development of SmartHeart and Evaluation of Feasibility and Acceptability
JMIR Research Protocols · 2025
- Clinical Features and Prospective Outcomes of Thin-Filament Hypertrophic Cardiomyopathy: Intrinsic Data and Comparative Insights from Other Cohorts
Journal of Clinical Medicine · 2025
- Perception and Evaluation of a Knowledge Transfer Concept in a Digital Health Application for Patients With Heart Failure: Mixed Methods Study
JMIR Human Factors · 2025
- Targeting Ketone Body Metabolism Improves Cardiac Function and Hemodynamics in Patients With Heart Failure: A Systematic Review and Meta-Analysis
Nutrition Reviews · 2025
- Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2/HO-1/GPX4 signaling pathway
PLoS ONE · 2025
- Pheochromocytoma Masquerading as Acute Coronary Syndrome and Takotsubo Cardiomyopathy: A Diagnostic Dilemma in the Elderly
Indian Journal of Cardiovascular Disease in Women · 2025
- MICRORNA-146B TARGETS HIF-1Α AND ATTENUATES CARDIOMYOCYTE APOPTOSIS AND FIBROSIS IN DOXORUBICIN-INDUCED HEART FAILURE
Shock · 2025
- Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure for Clinical Phenotypes
Circulation Cardiovascular Quality and Outcomes · 2025
- Usefulness of the LAVITA Telemonitoring System in Patients With Heart Failure ― A Feasibility Study ―
Circulation Reports · 2025
- Health-Related Quality of Life Across Heart Failure Categories: Associations with Clinical Characteristics and Outcomes
ESC Heart Failure · 2025
- Exploring the association between tissue sodium content, heart failure subtypes, and symptom burden: insights from magnetic resonance imaging
Frontiers in Cardiovascular Medicine · 2025
- Myocardial Inflammation in Cardiac Transthyretin Amyloidosis: Prevalence and Potential Prognostic Implications
Circulation Heart Failure · 2025
- Continuous Risk Monitoring and Management of Heart Failure: Rationale and Design of the ALLEVIATE-HF Trial
European Journal of Heart Failure · 2025
- BETA BLOCKER THERAPY IMPROVES RIGHT VENTRICULAR FUNCTIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Kocatepe tıp dergisi. · 2025
- Albumin–Bilirubin (ALBI) Score Predicts Long-Term Survival in Elderly Patients with Decompensated Heart Failure
Journal of Clinical Medicine · 2025
- Association of Baseline eGFR and Incident Heart Failure On Patients Receiving Intensive Blood Pressure Treatment
ESC Heart Failure · 2025
- Transcardiac gradients of pro-cholecystokinin, cholecystokinin, and gastrin in patients with and without heart failure with reduced ejection fraction
Peptides · 2025
- Clin‐ STAR Corner: Rehabilitation for Older Adults With Heart Failure
Journal of the American Geriatrics Society · 2025
- Baseline NT-proBNP nonresponse score and health status measures in assessing treatment responses in heart failure with reduced ejection fraction
American Heart Journal · 2025
- Left atrial shunting devices: why, what, how, and… when?
Heart Failure Reviews · 2025
- Elevated Lp(a) and its association with cardiac fibrosis in group II pulmonary hypertension patients
Future Cardiology · 2025
- Exergaming system for exercise-based cardiac rehabilitation in heart failure patients: HEFMOB development and usability assessment study (Preprint)
2025
- Ability of dynamic chest radiography to identify left ventricular systolic dysfunction in heart failure
The International Journal of Cardiovascular Imaging · 2025
- Atrial Functional Tricuspid Regurgitation (AFTR) Is Associated with Better Outcome After Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) Compared to Ventricular FTR (VFTR)
Journal of Clinical Medicine · 2025
- Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy
Circulation Genomic and Precision Medicine · 2025
- Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation
Medicina · 2025
- New Biomarkers in the Prognostic Assessment of Acute Heart Failure with Reduced Ejection Fraction: Beyond Natriuretic Peptides
International Journal of Molecular Sciences · 2025
- Redefining treatment paradigms: Early use of dapagliflozin and empagliflozin in acute heart failure – a systematic review and meta-analysis of randomized controlled trials
Narra J · 2025
- Circulating neuropeptide Y dynamics and performance during exercise in heart failure patients with contemporary medical and device therapy
Experimental Physiology · 2025
- Clinical and phenotypical profiles of patients with chronic heart failure with preserved ejection fraction
Russian Journal of Preventive Medicine · 2025
- Exploring the landscape of exosomes in heart failure: a bibliometric analysis
International Journal of Surgery · 2025
- Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
IJC Heart & Vasculature · 2025
- Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J‐<scp>DREAMS</scp> database
Journal of Diabetes Investigation · 2025
- Hypertrophic heart failure promotes gut dysbiosis and gut leakage in interleukin 10-deficient mice
American Journal of Physiology-Heart and Circulatory Physiology · 2025
- State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age
ESC Heart Failure · 2025
- SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established
Heart Failure Reviews · 2025
- Safety and efficacy of catheter ablation in atrial fibrillation patients with heart failure with preserved ejection fraction
BMC Cardiovascular Disorders · 2025
- Association Between Cardiometabolic Comorbidity Burden and Outcomes in Heart Failure
Journal of the American Heart Association · 2025
- Frailty Determinants in Heart Failure: Inflammatory mArkers, Cognitive Impairment and Psychosocial Interaction
ESC Heart Failure · 2025
- Patterns of beta-blocker use and dose optimization among ambulatory heart failure patients with reduced ejection fraction (HFrEF) attending public hospitals in Northeast Ethiopia: a multi-center cross-sectional study
BMC Cardiovascular Disorders · 2025
- Cardiovascular Reactivity to Mental Stress and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease
Journal of the American Heart Association · 2025
- Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant-Level Pooled Analysis of the CANVAS and CREDENCE Trials
European Journal of Heart Failure · 2025
- Causal relationship between immune cells and risk of heart failure: evidence from a Mendelian randomization study
Frontiers in Cardiovascular Medicine · 2025
- Cardiac Myosin Binding Protein C Correlate with Cardiac Troponin I During an Exercise Training Program in Patients with HFrEF
ESC Heart Failure · 2025
- The Early Pharmacological Strategy with Inodilator, bEta-blockers, Mineralocorticoid Receptor Antagonists, Sodium-glucose coTransporter-2 Inhibitors and Angiotensin Receptor-neprylisin Inhibitors in Acute Heart Failure (PENTA-HF)
Current Vascular Pharmacology · 2025